About 100 reports

  • APLEWAY SWOT ANALYSIS, 2016
  • LUSEFI SWOT ANALYSIS, 2016

IN ADDITION, PATIENTS EXPERIENCED WEIGHT LOSS OF APPROXIMATELY ##. ## KG, COMPARED TO PATIENTS RECEIVING PLACEBO THAT EXPERIENCED A WEIGHT LOSS OF JUST OVER ## KG.

  • Vaccine
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Sanofi S.A.

In older companion animals, hookworms cause diarrhea and weight loss because of excessive loss of blood.

  • Vaccine
  • World
  • Aratana Therapeutics, Inc.
  • Merial Limited
  • Zoetis Inc.

However, the effect of weight loss on the general risk of cancer among obese patients has been poorly characterized, as only a small proportion of obese people are able to achieve sustained weight loss (Wolin et al., 2010).

  • Cancer
  • Cancer Immunotherapy
  • Cell Therapy
  • Therapy
  • Vaccine
  • Bacillus Calmette-Guerin (BCG) Vaccine

THESE WEIGHTS ARE DERIVED FROM A NEW FORMULA ADOPTED BY THE IMF.

  • Vaccine
  • China
  • Demand
  • Market Size
  • Supply
  • Kinds of Vaccines
  • Kinds of Vaccines

THESE WEIGHTS ARE DERIVED FROM A NEW FORMULA ADOPTED BY THE IMF.

  • Vaccine
  • China
  • Market Size
  • Supply
  • Shenzhen Kangtai Biological Products Co.
  • 10.7 HEPATITIS - TOTAL VACCINES MARKET AND FORECAST

THERE IS NO SPECIFIC TREATMENT FOR NASH; HOWEVER, A HEALTHY LIFESTYLE, INCLUDING PHYSICAL ACTIVITY, A HEALTHY DIET, AND WEIGHT LOSS, IS IMPORTANT.

  • Vaccine
  • World
  • Forecast
  • Meningococcal group
  • Pfizer Inc.

IT IS EMBEDDED IN A RUBBER SHIELD TO PREVENT MEDICINE LOSS DUE TO SEEPAGE.

  • Neurological Disorder
  • Vaccine
  • World
  • Forecast
  • Antares Pharma, Inc.

IF BLADDER CANCER REACHES AN ADVANCED STAGE AND BEGINS TO SPREAD, THE SYMPTOMS CAN INCLUDE PELVIC PAIN, BONE PAIN, UNEXPLAINED WEIGHT LOSS, AND SWELLING OF THE LEGS.

  • Vaccine
  • United States
  • Demand
  • Merck & Co., Inc.
  • OncoGenex Pharmaceuticals, Inc.
  • 9.7 HEPATITIS - ADULT VACCINES MARKET AND FORECAST

THERE IS NO SPECIFIC TREATMENT FOR NASH; HOWEVER, A HEALTHY LIFESTYLE, INCLUDING PHYSICAL ACTIVITY, A HEALTHY DIET, AND WEIGHT LOSS, IS IMPORTANT.

  • Vaccine
  • World
  • GlaxoSmithKline plc
  • Meningococcal group
  • Pfizer Inc.

THERE IS NO SPECIFIC TREATMENT FOR NASH; HOWEVER, A HEALTHY LIFESTYLE, INCLUDING PHYSICAL ACTIVITY, A HEALTHY DIET, AND WEIGHT LOSS, IS IMPORTANT.

  • Vaccine
  • World
  • Forecast
  • Meningococcal group
  • Pfizer Inc.

(Korea) ##.

  • PET
  • Vaccine
  • World
  • Demand
  • Market Shares

One particular device, the Med-E-Jet, was implicated in a 1985 outbreak of hepatitis B among clients of a California weight-loss clinic who received injections of human chorionic gonadotropin.

  • Vaccine
  • Bioject Medical Technologies Inc.
  • Crossject
  • Inovio Pharmaceuticals, Inc.
  • MedImmune, LLC

Metastatic breast cancer has a variety of non-specific symptoms, such as unexplained weight loss, fever, chills, and bone pain.

  • Cancer Immunotherapy
  • Immunotherapy
  • Monoclonal Antibody
  • Therapy
  • Vaccine

Additionally, nitazoxanide monotherapy in one case and nitazoxanide plus adefovir in another case resulted in undetectable HBV DNA, loss of HBeAg and loss of HBsAg.

  • Infectious Disease
  • Vaccine
  • United States
  • World
  • Product Initiative
  • AV-5075S - DRUG PROFILE
  • GAMMA-FLU - DRUG PROFILE

THE PROTECTED BPZE##-IMMUNIZED MICE SHOWED A REDUCED BODY WEIGHT LOSS AS WELL AS A SIGNIFICANTLY LOWER VIRAL LOAD IN THEIR LUNGS COMPARED TO NON IMMUNIZED MICE.

  • Vaccine
  • United States
  • World
  • Product Initiative
  • BiondVax Pharmaceuticals Ltd.
  • Research and Development Brief
  • HB-36.6 - DRUG PROFILE

A single dose of VH## administered on either day -##, ##, ## or ## post PVM infection prevented disease and significant weight loss, demonstrating a long therapeutic window for intervention post infection.

  • Influenza
  • Monoclonal Antibody
  • Vaccine
  • United States
  • Product Initiative
  • Influenza A Virus, H3N2 Subtype Infections - Drug Profiles
  • GAMMA-FLU - DRUG PROFILE

THE PROTECTED BPZE##-IMMUNIZED MICE SHOWED A REDUCED BODY WEIGHT LOSS AS WELL AS A SIGNIFICANTLY LOWER VIRAL LOAD IN THEIR LUNGS COMPARED TO NONIMMUNIZED MICE.

  • Influenza
  • Vaccine
  • United States
  • Product Initiative
  • BiondVax Pharmaceuticals Ltd.

AS SHOWN IN TABLE ##-##, SEVERAL VERY SIGNIFICANT PRODUCTS HAVE SWITCHED RECENTLY INCLUDING ZEGERID AND PREVACID ANTACIDS, ZYRTEC ALLERGY MEDICATION, MIRALAX LAXATIVE AND ALLI FOR WEIGHT LOSS.

  • Vaccine
  • United States
  • Demand
  • Market Size
  • Walgreens Boots Alliance, Inc.

Symptoms include sore throat, runny nose, sneezing, fatigue, headache and loss of appetite.

  • Infectious Disease
  • Vaccine
  • United States
  • World
  • Product Initiative
  • HB-36.6 - DRUG PROFILE
  • Research and Development Brief

This one-time HB##. ## treatment, when given up to ## hours before the challenge, conveyed complete protection: All of the treated mice survived and had little weight loss, whereas all untreated control mice died after losing a third of their body weight or more.

  • Influenza
  • Therapy
  • Vaccine
  • United States
  • Product Initiative
  • Research and Development Brief

EFFICACY OF UV-##B AGAINST INFLUENZA A (H##N## AND H##N## SUBTYPES) AND INFLUENZA B WAS DEMONSTRATED USING MULTIPLE LETHAL MOUSE MODELS WITH READOUTS INCLUDING MORTALITY AND WEIGHT LOSS.

  • Vaccine
  • Australia
  • United States
  • World
  • Product Initiative
  • Zika Virus Infections - Drug Profiles

The primary endpoint of the study, an eight (##) week mean percent lesion area loss demonstrated a seventy-one (-## percent) percent mean area loss for topical ranpirnase versus thirty-three (-## percent) percent mean area loss for vehicle (p ##. ##).

  • Infectious Disease
  • Pharmaceutical
  • Research And Development
  • Therapy
  • Vaccine

IMM-##E was administered orally after the onset of colitis symptoms such as weight loss and macroscopically inflamed colon were confirmed by colonoscopy prior to the initiation of treatment.

  • Infectious Disease
  • Vaccine
  • World
  • Product Initiative
  • Immuron Limited

The net loss of the company was US$##. ## million in FY2017, compared to a net loss of US$##. ## million in FY2016.

  • Biopharmaceutical
  • Digestive System Disorder
  • Gastrointestinal Drug
  • Pharmaceutical
  • Vaccine

The net loss of the company was AUD##. ## million in FY2017, compared to a net loss of AUD## million in FY2016.

  • Infectious Disease
  • Pharmaceutical
  • Research And Development
  • Therapy
  • Vaccine
  • CHLAMYDIA VACCINE - DRUG PROFILE

The net loss of the company was EUR##. ## million in FY2016, compared to a net loss of EUR## million in FY2015.

  • Sexually Transmitted Disease
  • Vaccine
  • United States
  • Product Initiative
  • Cempra, Inc.

SMALL MOLECULES TO ANTAGONIZE MCHR## FOR WEIGHT LOSS - DRUG PROFILE Small Molecules to Antagonize MCHR## for Weight Loss Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description LEO Pharma A/ S NA NA Small molecules are

  • Therapy
  • Vaccine
  • United States
  • World
  • Product Initiative

IMM-##E was administered orally after the onset of colitis symptoms such as weight loss and macroscopically inflamed colon were confirmed by colonoscopy prior to the initiation of treatment.

  • Infectious Disease
  • Vaccine
  • World
  • Product Initiative
  • Immuron Limited
  • MT-7529 - DRUG PROFILE

Similar to the survival results, the mice treated with NV-INF-## maintained their body weight substantially longer, through day ##.

  • Influenza
  • Vaccine
  • United States
  • Company Operations
  • NanoViricides, Inc.
  • HB-36.6 - DRUG PROFILE
  • Influenza A Virus, H5N1 Subtype Infections - Drug Profiles

A SINGLE DOSE OF VH## ADMINISTERED ON EITHER DAY -##, ##, ## OR ## POST PVM INFECTION PREVENTED DISEASE AND SIGNIFICANT WEIGHT LOSS, DEMONSTRATING A LONG THERAPEUTIC WINDOW FOR INTERVENTION POST INFECTION.

  • Vaccine
  • United States
  • World
  • Product Initiative
  • Hemispherx Biopharma, Inc.